Search Results - "Hsu, Charles C"

Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy by Shiraishi, Yutaka, Fang, Penny, Xu, Cai, Song, Juhee, Krishnan, Sunil, Koay, Eugene J., Mehran, Reza J., Hofstetter, Wayne L., Blum-Murphy, Mariela, Ajani, Jaffer A., Komaki, Ritsuko, Minsky, Bruce, Mohan, Radhe, Hsu, Charles C., Hobbs, Brian P., Lin, Steven H.

“…Circulating lymphocytes are exquisitely sensitive to radiation exposure, even to low scattered doses which can vary drastically between radiation modalities…”
Get full text

Analysis of Fluorouracil-Based Adjuvant Chemotherapy and Radiation After Pancreaticoduodenectomy for Ductal Adenocarcinoma of the Pancreas: Results of a Large, Prospectively Collected Database at the Johns Hopkins Hospital by HERMAN, Joseph M, SWARTZ, Michael J, CAMPBELL, Kurtis A, WOLFGANG, Christopher L, ASRARI, Fariba, DONEHOWER, Ross, HIDALGO, Manuel, DIAZ, Luis A, YEO, Charles, CAMERON, John L, SCHULICK, Richard D, ABRAMS, Ross, HSU, Charles C, WINTER, Jordan, PAWLIK, Timothy M, SUGAR, Elizabeth, ROBINSON, Ray, LAHERU, Daniel A, JAFFEE, Elizabeth, HRUBAN, Ralph H

“…To examine the efficacy of adjuvant chemoradiotherapy after pancreaticoduodenectomy (PD) for pancreatic adenocarcinoma (PC) in patients undergoing resection at…”
Get full text

Adjuvant Chemoradiation for Pancreatic Adenocarcinoma: The Johns Hopkins Hospital—Mayo Clinic Collaborative Study by Hsu, Charles C., Herman, Joseph M., Corsini, Michele M., Winter, Jordan M., Callister, Matthew D., Haddock, Michael G., Cameron, John L., Pawlik, Timothy M., Schulick, Richard D., Wolfgang, Christopher L., Laheru, Daniel A., Farnell, Michael B., Swartz, Michael J., Gunderson, Leonard L., Miller, Robert C.

“…Background Survival for pancreatic ductal adenocarcinoma is low, the role of adjuvant therapy remains controversial, and recent data suggest adjuvant…”
Get full text

Feasibility of MR Imaging/MR Spectroscopy-Planned Focal Partial Salvage Permanent Prostate Implant (PPI) for Localized Recurrence After Initial PPI for Prostate Cancer by Hsu, Charles C., MD, PhD, Hsu, Howard, MD, Pickett, Barby, MS, Crehange, Gilles, MD, PhD, Hsu, I-Chow Joe, MD, Dea, Ryan, BS, Weinberg, Vivian, PhD, Gottschalk, Alexander R., MD, PhD, Kurhanewicz, John, PhD, Shinohara, Katsuto, MD, Roach, Mack, MD

“…Purpose To assess the feasibility of magnetic resonance imaging (MRI)-planned partial salvage permanent prostate implant (psPPI) among patients with…”
Get full text

Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study by Narang, Amol K, Miller, Robert C, Hsu, Charles C, Bhatia, Sumita, Pawlik, Timothy M, Laheru, Dan, Hruban, Ralph H, Zhou, Jessica, Winter, Jordan M, Haddock, Michael G, Donohue, John H, Schulick, Richard D, Wolfgang, Christopher L, Cameron, John L, Herman, Joseph M

“…The role of adjuvant chemoradiation therapy for ampullary carcinoma is unknown. Previous literature suggests that certain populations with high risk factors…”
Get full text

Early Mortality Risk Score: Identification of Poor Outcomes Following Upfront Surgery for Resectable Pancreatic Cancer by Hsu, Charles C., Wolfgang, Christopher L., Laheru, Daniel A., Pawlik, Timothy M., Swartz, Michael J., Winter, Jordan M., Robinson, Raymond, Edil, Barish H., Narang, Amol K., Choti, Michael A., Hruban, Ralph H., Cameron, John L., Schulick, Richard D., Herman, Joseph M.

“…Background Identifying pancreatic cancer patients at high risk of early mortality following pancreaticoduodenectomy (PD) is important for treatment decisions…”
Get full text

Resected pancreatic adenosquamous carcinoma: clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patients by Voong, K. Ranh, BA, Davison, Jon, MD, Pawlik, Timothy M., MD, Uy, Manuel O., PhD, Hsu, Charles C., MD, Winter, Jordan, MD, Hruban, Ralph H., MD, Laheru, Daniel, MD, Rudra, Sonali, MD, Swartz, Michael J., MD, Nathan, Hari, MD, Edil, Barish H., MD, Schulick, Richard, MD, Cameron, John L., MD, Wolfgang, Christopher L., MD, Herman, Joseph M., MD, MSc

“…Summary Pancreatic adenosquamous carcinoma is a rare morphological variant of pancreatic adenocarcinoma with an especially poor prognosis. The purpose of this…”
Get full text

Eluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital - Mayo Clinic collaborative study by Narang, Amol K, Miller, Robert C, Hsu, Charles C, Bhatia, Sumita, Pawlik, Timothy M, Laheru, Dan, Hruban, Ralph H, Zhou, Jessica, Winter, Jordan M, Haddock, Michael G, Donohue, John H, Schulick, Richard D, Wolfgang, Christopher L, Cameron, John L, Herman, Joseph M

“…Background The role of adjuvant chemoradiation therapy for ampullary carcinoma is unknown. Previous literature suggests that certain populations with high risk…”
Get full text

Adjuvant Chemoradiotherapy After Pancreatic Resection for Invasive Carcinoma Associated With Intraductal Papillary Mucinous Neoplasm of the Pancreas by Swartz, Michael J., M.D, Hsu, Charles C., M.D., Ph.D, Pawlik, Timothy M., M.D., M.P.H, Winter, Jordan, M.D, Hruban, Ralph H., M.D, Guler, Mehmet, M.D, Schulick, Richard D., M.D, Cameron, John L., M.D, Laheru, Daniel A., M.D, Wolfgang, Christopher L., M.D., Ph.D, Herman, Joseph M., M.D., M.Sc

“…Purpose Intraductal papillary mucinous neoplasms are mucin-producing cystic neoplasms of the pancreas. One-third are associated with invasive carcinoma. We…”
Get full text

Adjuvant Chemoradiation Therapy After Pancreaticoduodenectomy in Elderly Patients With Pancreatic Adenocarcinoma by Horowitz, David P., M.D, Hsu, Charles C., M.D., Ph.D, Wang, Jingya, M.D, Makary, Martin A., M.D., M.P.H, Winter, Jordan M., M.D, Robinson, Ray, B.S, Schulick, Richard D., M.D, Cameron, John L., M.D, Pawlik, Timothy M., M.D., M.P.H, Herman, Joseph M., M.D., M.Sc

“…Purpose To evaluate the efficacy of adjuvant chemoradiation therapy (CRT) for pancreatic adenocarcinoma patients ≥75 years of age. Methods The study group of…”
Get full text

Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy by Davuluri, Rajayogesh, Jiang, Wen, Fang, Penny, Xu, Cai, Komaki, Ritsuko, Gomez, Daniel R., Welsh, James, Cox, James D., Crane, Christopher H., Hsu, Charles C., Lin, Steven H.

“…Host immunity may affect the outcome in patients with esophageal cancer. We sought to identify factors that influenced absolute lymphocyte count (ALC) nadir…”
Get full text

FAE: Autoencoder-Based Failure Binning of RTL Designs for Verification and Debugging by Shen, Cheng-Hsien, Liang, Aaron C.-W., Hsu, Charles C.-H., Wen, Charles H.-P.

“…As the Register Transfer Level (RTL) designs are more complicated, debugging becomes a major bottleneck in the design process. To make debugging more…”
Get full text

The Role of Adjuvant Therapy in Advanced Thymic Carcinoma: A National Cancer Database Analysis by Kim, Samuel, Bull, David A., Hsu, Chiu-Hsieh, Hsu, Charles C.

“…There is area of controversy and variability in the recommendation for the role of adjuvant therapy after R0 resection of a Masaoka stage IIB and III thymic…”
Get full text

Image Guided Volumetric Response During Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma as a Predictor of Disease Outcomes by Davuluri, Rajayogesh, MD, Krase, Jeff M., MD, Cui, Haiyan, PhD, Goyal, Uma D., MD, Cheung, Michael K., MD, Hsu, Charles C., MD, PhD, Yi, Sun K., MD

“…Abstract Purpose The goal of this study was to correlate volumetric image guided disease response to clinical outcomes in patients receiving chemoradiation…”
Get full text

High lymphocyte count during neoadjuvant chemoradiotherapy is associated with improved pathologic complete response in esophageal cancer by Fang, Penny, Jiang, Wen, Davuluri, Rajayogesh, Xu, Cai, Krishnan, Sunil, Mohan, Radhe, Koong, Albert C., Hsu, Charles C., Lin, Steven H.

“…Neoadjuvant chemoradiation (nCRT) can reduce tumor infiltrating lymphocytes. We examined absolute lymphocyte count (ALC) nadir during nCRT for esophageal…”
Get full text

The Association of Podocin R229Q Polymorphism With Increased Albuminuria or Reduced Estimated GFR in a Large Population-Based Sample of US Adults by Köttgen, Anna, MD, MPH, Hsu, Charles C., PhD, Coresh, Josef, MD, PhD, Shuldiner, Alan R., MD, Berthier-Schaad, Yvette, PhD, Gambhir, Tejal Rami, MPH, Smith, Michael W., PhD, Boerwinkle, Eric, PhD, Kao, W.H. Linda, PhD, MHS

“…Background Rare mutations in nephrosis 2 ( NPHS2 ), encoding podocin, are found in patients with familial and sporadic steroid-resistant nephrotic syndrome and…”
Get full text

Is There a Role for Cancer-Directed Surgery in Early-Stage Sarcomatoid or Biphasic Mesothelioma? by Kim, Samuel, Bull, David A., Garland, Linda, Khalpey, Zain, Stea, Baldasarre, Yi, Sun, Hsu, Charles C.

“…Benefits of surgical resection for early-stage nonepithelioid malignant pleural mesothelioma (MPM) have not been clearly elucidated. This study investigated…”
Get full text

The role of radiation therapy in the treatment of metastatic cancer by Stea, Baldassarre, Skrepnik, Tijana, Hsu, Charles C., Abendroth, Roy

“…Radiation therapy continues to play an important role in the management of cancer. In this review, we discuss the use of radiation therapy to target and…”
Get full text

Genetic variation of glucose transporter-1 (GLUT1) and albuminuria in 10,278 European Americans and African Americans: a case-control study in the Atherosclerosis Risk in Communities (ARIC) study by Hsu, Charles C, Kao, Wenhong L, Steffes, Michael W, Gambir, Tejal, Brancati, Frederick L, Heilig, Charles W, Shuldiner, Alan R, Boerwinkle, Eric A, Coresh, Josef

“…Evidence suggests glucose transporter-1 (GLUT1) genetic variation affects diabetic nephropathy and albuminuria. Our aim was to evaluate associations with…”
Get full text

Neoadjuvant chemotherapy improves survival compared with concurrent chemoradiation alone in nasopharyngeal carcinoma patients with N3 disease by Han, James E., Yi, Sun K., Wang, Steven, Erman, Audrey, Bearelly, Shethal, Sindhu, Simran, Robbins, Jared R., Bauman, Julie, Hsu, Charles C.

“…Background Neoadjuvant chemotherapy (NAC) trials in endemic regions of nasopharyngeal carcinoma (NPC) found improved survival, but studies are lacking in…”
Get full text